- “Maybe He Doesn’t Want to Be the Hero”: In the COVID-19 Crisis, Warren Buffett is Lying Low (Vanity Fair)
- Virus Vaccine May Be Ready for Mass Production By Autumn, Oxford Professor Says (Bloomberg)
- Gilead Gains on Report Claiming Coronavirus Drug Working (Bloomberg)
- Covid Report: Gilead Pops On Promising Sneak Peek For Coronavirus Drug (Investor’s Business Daily)
- The Fear Gauge Is Sending False Signals (Barron’s)
- Why Emerging Market Currencies Are Cheap (Barron’s)
- Treasury yields follow stocks higher on hopes for coronavirus drug MarketWatch)
- AMC Entertainment’s stock rockets after liquidity update, private debt offering (MarketWatch)
- Schlumberger swings to large loss, misses revenue and cuts dividend by 75%; stock surges (MarketWatch)
- Trump administration working to ease drilling industry cash crunch (Reuters)
- Johnson & Johnson execs offer upbeat view of second-half recovery from COVID-19 pandemic (MarketWatch)
- Fed’s Bostic says watching closely for signs of ‘unbearable’ stress among mortgage servicers (MarketWatch)
- Boeing to Restart Jetliner Production (Wall Street Journal)
- Mnuchin Under Growing Pressure to Help Struggling Mortgage Companies (Wall Street Journal)
- Screening Rooms That Bring Hollywood Home (Wall Street Journal)